PT820303E - Analogos do peptido p277 e composicoes farmaceuticas que os compreendem, para tratamento ou diagnostico de diabetes - Google Patents

Analogos do peptido p277 e composicoes farmaceuticas que os compreendem, para tratamento ou diagnostico de diabetes

Info

Publication number
PT820303E
PT820303E PT95944502T PT95944502T PT820303E PT 820303 E PT820303 E PT 820303E PT 95944502 T PT95944502 T PT 95944502T PT 95944502 T PT95944502 T PT 95944502T PT 820303 E PT820303 E PT 820303E
Authority
PT
Portugal
Prior art keywords
diabetes
peptide
diagnosis
understand
analysis
Prior art date
Application number
PT95944502T
Other languages
English (en)
Inventor
Matityahu Fridkin
Irun R Cohen
Dana Elias
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT820303(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of PT820303E publication Critical patent/PT820303E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT95944502T 1994-12-21 1995-12-20 Analogos do peptido p277 e composicoes farmaceuticas que os compreendem, para tratamento ou diagnostico de diabetes PT820303E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes

Publications (1)

Publication Number Publication Date
PT820303E true PT820303E (pt) 2003-10-31

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95944502T PT820303E (pt) 1994-12-21 1995-12-20 Analogos do peptido p277 e composicoes farmaceuticas que os compreendem, para tratamento ou diagnostico de diabetes

Country Status (31)

Country Link
EP (1) EP0820303B1 (pt)
JP (2) JP3420245B2 (pt)
KR (1) KR100400480B1 (pt)
CN (1) CN1233417C (pt)
AR (1) AR002949A1 (pt)
AT (1) ATE242005T1 (pt)
AU (1) AU707835B2 (pt)
BR (1) BR9510102A (pt)
CA (1) CA2208274C (pt)
CZ (1) CZ293784B6 (pt)
DE (2) DE820303T1 (pt)
DK (1) DK0820303T3 (pt)
ES (1) ES2201137T3 (pt)
FI (1) FI118373B (pt)
HR (1) HRP950612B1 (pt)
HU (1) HU224160B1 (pt)
IL (1) IL116499A0 (pt)
IS (1) IS1966B (pt)
MX (1) MX9704738A (pt)
NO (1) NO317350B1 (pt)
NZ (1) NZ301440A (pt)
PL (1) PL184145B1 (pt)
PT (1) PT820303E (pt)
RO (1) RO116777B1 (pt)
RS (1) RS49517B (pt)
SI (1) SI0820303T1 (pt)
TR (1) TR199501630A2 (pt)
TW (1) TW496872B (pt)
UA (1) UA42040C2 (pt)
UY (1) UY24130A1 (pt)
WO (1) WO1996019236A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
EP0914614B1 (en) * 1996-05-14 2003-09-03 Winnacker, Ernst-Ludwig, Prof. CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
EP2157101B1 (en) 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP peptides and analogs for modulation of immune responses via antigen presenting cells
EP1718158B1 (en) * 2004-01-28 2014-07-02 Andromeda Bio Tech Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
WO2006072946A2 (en) 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
EP1858545A2 (en) * 2005-03-04 2007-11-28 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
CA2609667C (en) 2005-05-25 2011-02-22 Curedm, Inc. Human proislet peptide, derivatives and analogs thereof, and methods of using same
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
US8785400B2 (en) 2006-11-22 2014-07-22 Curedm Group Holdings, Llc Methods and compositions relating to islet cell neogenesis
NZ583679A (en) 2007-08-30 2012-05-25 Curedm Group Holdings Llc Compositions and methods of using proislet peptides and analogs thereof
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
CZ293784B6 (cs) 2004-07-14
MX9704738A (es) 1997-10-31
DE69531004T2 (de) 2004-02-05
FI118373B (fi) 2007-10-31
EP0820303A4 (pt) 1998-03-11
JP3554319B2 (ja) 2004-08-18
AU4686696A (en) 1996-07-10
IS1966B (is) 2004-12-15
AU707835B2 (en) 1999-07-22
SI0820303T1 (en) 2003-10-31
HRP950612A2 (en) 1997-10-31
NO317350B1 (no) 2004-10-18
YU78795A (sh) 1998-05-15
PL321091A1 (en) 1997-11-24
CA2208274C (en) 2005-12-06
JP2004026797A (ja) 2004-01-29
DE820303T1 (de) 1999-05-20
HU224160B1 (hu) 2005-06-28
RO116777B1 (ro) 2001-06-29
HUT78092A (hu) 1999-09-28
UY24130A1 (es) 1996-06-11
FI972669A0 (fi) 1997-06-19
FI972669A (fi) 1997-08-15
ES2201137T3 (es) 2004-03-16
DE69531004D1 (de) 2003-07-10
HRP950612B1 (en) 2003-12-31
NO972849L (no) 1997-08-13
PL184145B1 (pl) 2002-09-30
JP3420245B2 (ja) 2003-06-23
BR9510102A (pt) 1997-11-25
TW496872B (en) 2002-08-01
EP0820303A1 (en) 1998-01-28
IL116499A0 (en) 1996-03-31
EP0820303B1 (en) 2003-06-04
IS4510A (is) 1997-06-19
KR100400480B1 (ko) 2003-12-31
CZ190897A3 (en) 1997-11-12
WO1996019236A1 (en) 1996-06-27
AR002949A1 (es) 1998-05-27
ATE242005T1 (de) 2003-06-15
CA2208274A1 (en) 1996-06-27
RS49517B (sr) 2006-10-27
JPH10511649A (ja) 1998-11-10
UA42040C2 (uk) 2001-10-15
NO972849D0 (no) 1997-06-19
CN1233417C (zh) 2005-12-28
DK0820303T3 (da) 2003-10-06
CN1175214A (zh) 1998-03-04
TR199501630A2 (tr) 1996-07-21
NZ301440A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
PT820303E (pt) Analogos do peptido p277 e composicoes farmaceuticas que os compreendem, para tratamento ou diagnostico de diabetes
BR9711098B1 (pt) compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
BR9710359A (pt) Composto formulacao farmaceutica uso de um composto e processos para a preparacao de um composto e para tratamento de um individuo humano ou animal que esteja sofrendo de um disturbio mediado por atividade aberrante de tirosina cinase proteinica
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
BR9814386B1 (pt) aparelhos e métodos para determinar a concentração de um componente medicamente significante de um fluido biológico.
BR9710362A (pt) Composto formula-ao farmaceutica utiliza-ao de um composto processos de tratamento de um ser humano ou animal sofrendo de uma mediada por atividade anormal de cinase de proteina tirosina e para a prepara-ao de um composto
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
BR9800660A (pt) Emulsão água-em-óleo sua utilização composição cosmética e/ou dermatológica processo de tratamento cosmético e utilzação de uma associação
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
FR2737118B1 (fr) Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
FI963410A0 (fi) Laite nestemäisten näytteiden, kuten verinäytteideLaite nestemäisten näytteiden, kuten verinäytteiden ottamiseksi ja analysoimiseksi n ottamiseksi ja analysoimiseksi
BR9708714A (pt) Proteína composição farmacéutica uso da proteína animais que sofrem de artrite uso dos animais e dna isolado
BR9601478A (pt) Utilizações de ao menos um antagonista de CGRP composição cosmética farmacêutica e/ou dermatológica processo de tratamento cosmético de vermilhidões cutâneas e processo de tratamento cosmético de rosásea e/ou de eritema pudico
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
BR9609327A (pt) Novos derivados de oxazolidinona processos para sua preparação e agentes farmacêuticos que contêm estes compostos
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
BR9506106A (pt) Composto processo para sua preparação medicamento e composição farmacêutica
BR9610733A (pt) Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto
BR9611302A (pt) Utilização de pelo menos um agonista beta-adrenérgico processo de tratamento cosmético e composição cosmética ou farmacêutica
PT915087E (pt) Compostos anelados de cinco aneis, susbtituidos por sulfonamida, sua utilizacao como medicamentos, bem como preparacoes farmaceuticas contendo os mesmos
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
PT1128841E (pt) Composicao farmaceutica contendo um antagonista de receptor para o tratamento de disturbios da coagulacao sanguinea
BR9912378A (pt) Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição para diagnóstico.
BR8906960A (pt) Processo para obtencao de peptidio,molecula dna,composicao farmaceutica,processo para utilizacao de peptidio,intermediario de peptidio-resina e reagente de diagnostico